In conclusion, our findings suggest that IHP may enhance TH2 inflammatory responses through the NF‐κB pathway, leading to exacerbated airway inflammation, increased airway hyperresponsiveness, and ultimately worsening of asthma symptoms. This evidence concerns the gene NFKB1 and airway hyperresponsiveness.